Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease - Wikidata - awgldk - TriplyDB

Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease

Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease

http://www.wikidata.org/entity/Q36047282

about

Magnesium and type 2 diabetes Magnesium in CKD: more than a calcification inhibitor?Diabetes mellitus and electrolyte disorders.Results from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney disease Decreased urine uric acid excretion is an independent risk factor for chronic kidney disease but not for carotid atherosclerosis in hospital-based patients with type 2 diabetes: a cross-sectional study Low Magnesium Exacerbates Osteoporosis in Chronic Kidney Disease Patients with Diabetes.Cardiac and renal function in patients with type 2 diabetes who have chronic kidney disease: potential effects of bardoxolone methyl.Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.Hypomagnesemia and Mortality in Incident Hemodialysis Patients Sevelamer carbonate reduces the risk of hypomagnesemia in hemodialysis-requiring end-stage renal disease patients Low serum magnesium levels are associated with impaired peripheral nerve function in type 2 diabetic patients Effects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies.Hypomagnesemia, chronic kidney disease and cardiovascular mortality: pronounced association but unproven causation.Addressing uncertainties in renal transplantation: hypomagnesemia and the case of diabetes prevention.Magnesium and cardiovascular complications of chronic kidney disease.Magnesium and disturbances in carbohydrate metabolism.Clinical features of CKD-MBD in Japan: cohort studies and registry.Dietary Magnesium and Kidney Function Decline: The Healthy Aging in Neighborhoods of Diversity across the Life Span Study.Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.Protective effect of magnesium on renal function in STZ-induced diabetic rats Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials.Summary of the 2018 ISN Frontiers Meeting: Kidney Disease and Cardiovascular Disease.VEGF genetic polymorphisms may contribute to the risk of diabetic nephropathy in patients with diabetes mellitus: a meta-analysis

P2860

Q26795771-F3BB62F0-C131-4388-9A87-A5743A68C1D0 Q27027086-CAC778FB-6A99-4306-BBCB-E5C5B08B1D7C Q34344884-431446ED-2C49-404B-A62A-BB64E09E3FA5 Q35243414-F02F49E8-46F5-460D-AF8D-4E4765FFF48B Q35518966-AD8D3CAC-D373-42F7-9145-44A28BC4A0F2 Q35932324-D6905419-139F-4865-82C9-70D2C44EEAFD Q36083217-6CB2B81C-AF6F-4B78-919C-775714B3FDF1 Q36094152-5880E637-2D4F-48A4-B141-7E5F68EFA60D Q36315868-A3A50D8C-3C72-4E25-B094-28D80CB0D0B7 Q36951232-B5A566B3-8443-4307-B962-8806670272F6 Q37236893-4E7726AA-7F77-45E2-9F0C-9D1728A352B5 Q37673143-C68FC1BB-32F2-4185-97FF-BC8862183DF8 Q38196961-D4781D18-A55D-454C-8AFA-D15C98C7939E Q38213854-058B9ED9-D6BE-40C5-BA62-6DE5075452EB Q38473932-D5AFD0F6-646B-4B99-9D1D-CF98547E9BD0 Q38479670-B984D07A-074A-4E33-9856-30D0421AAB41 Q38784139-16B3A0CE-2097-48F9-840C-A66A10146271 Q40414969-344B6AFB-41EF-41D0-ABA0-F95D3D4395F5 Q40799000-487086B9-8D49-4144-A020-38AC844276E9 Q41882971-75B45327-9089-4740-BABF-1BDB1951984C Q54963847-5CE37350-CDE7-4811-A829-5034676B95C0 Q55476169-64C3FB47-9643-4780-85F2-DE6046C26367 Q59100561-BF26E0F9-126C-4E88-B3B5-FD649B92C578

P2860

Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease

http://www.wikidata.org/entity/Q36047282

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Hypomagnesemia in type 2 diabe ...... tor of end-stage renal disease

@ast

Hypomagnesemia in type 2 diabe ...... tor of end-stage renal disease

@en

type

label

Hypomagnesemia in type 2 diabe ...... tor of end-stage renal disease

@ast

Hypomagnesemia in type 2 diabe ...... tor of end-stage renal disease

@en

prefLabel

Hypomagnesemia in type 2 diabe ...... tor of end-stage renal disease

@ast

Hypomagnesemia in type 2 diabe ...... tor of end-stage renal disease

@en

P1433

Q36047282-545F5D93-3663-4F88-B287-1E98D2B7AD1F

P1476

Q36047282-A8354AE3-B44E-4E99-951D-E156FA6B9379

P2093

Q36047282-173007C9-B2A7-4780-AB37-0E168CF78AE2

Q36047282-1CCF30A2-FD7B-4FB0-B5F2-DE3A413536BB

Q36047282-2A3090B2-7B2E-4AC7-B66C-9AC65032EF98

Q36047282-2BF3B8E3-0AC5-4901-B0C9-212FF41C927A

Q36047282-89B94752-FDD5-4411-B2F6-0119F05164A3

Q36047282-AACD194A-0473-4A56-BE63-0B24F95E5254

Q36047282-C31AF948-4E3F-455A-A3FC-EC79CAEB6723

Q36047282-CF90AF33-4064-4302-A822-5F9658891C60

Q36047282-E6EAF07D-4470-450D-A835-4E91D69236AB

Q36047282-E865302C-832D-4409-8054-AE2D69A84F64

P2860

Q36047282-026940DE-E6D0-4F9F-B0EF-512469C13ED9

Q36047282-05769FF8-9EFC-4FEE-8F99-5ABE5A733D3A

Q36047282-10EF8162-BFB8-4C01-8A61-307579434E77

Q36047282-23273C9E-9ECB-4587-9E3D-B0F9B123DBCE

Q36047282-304DBB67-20A8-49F0-905C-97C64E53EAC4

Q36047282-3207E6C8-D5FC-4C8F-98F8-1339E92C1AB5

Q36047282-3A0C2303-FFE1-485C-BCB8-91635642080F

Q36047282-4241513B-FB5D-46C1-AD3C-C17E5FBACBA5

Q36047282-4A0508E9-74F7-4734-889A-C55E44DDA867

Q36047282-4FA055D2-17B8-482B-B2F5-AD7C353C24EF

P304

Q36047282-2383B65F-EE25-4698-8C74-A2F696B03D77

P31

Q36047282-DC9F6DDF-389F-40F3-A387-2E8591D97FA7

P356

Q36047282-4BDADC5A-195B-414A-9562-B2F0ED40A907

P407

Q36047282-27307290-0B9F-47E1-9387-E3E44D7C7101

P433

Q36047282-617B4ED0-E4B8-41C3-99DC-7564C46016EB

P478

Q36047282-44623004-EF39-482B-A7D2-BE6523541F0F

P50

Q36047282-E6224736-37E4-433F-AACC-FE8254DA6123

P577

Q36047282-B3F9639D-2E9B-4318-AB00-9BFBB4C4CD91

P5875

Q36047282-E7CA434A-556A-4B5C-B86F-4A29C7CBFB03

P698

Q36047282-4998DF3A-DC85-45B8-B77D-F5A7B38D4AE0

P932

Q36047282-6B0B595C-FFE4-44B9-A2A2-351DD1B03ECD

P356

P1433

P1476

Hypomagnesemia in type 2 diabe ...... tor of end-stage renal disease

@en

P2093

Akira Suzuki

http://www.w3.org/2001/XMLSchema#string

Hiroaki Kawabata

http://www.w3.org/2001/XMLSchema#string

Kakuya Niihata

http://www.w3.org/2001/XMLSchema#string

Kensuke Mitsumoto

http://www.w3.org/2001/XMLSchema#string

Morihiro Shimizu

http://www.w3.org/2001/XMLSchema#string

Noriyuki Okada

http://www.w3.org/2001/XMLSchema#string

Tatsuya Shoji

http://www.w3.org/2001/XMLSchema#string

Terumasa Hayashi

http://www.w3.org/2001/XMLSchema#string

Yoshiharu Tsubakihara

http://www.w3.org/2001/XMLSchema#string

Yoshitaka Isaka

http://www.w3.org/2001/XMLSchema#string

P2860

Magnesium metabolism and its disorders

Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2

Assessment of magnesium status.

Low serum magnesium levels and metabolic syndrome.

Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies.

Magnesium and the inflammatory response: potential physiopathological implications.

Hypomagnesemia in patients with type 2 diabetes.

Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese.

Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis Risk in Communities Study

Control of magnesium transport in the thick ascending limb.

P304

1591-1597

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC12-0226

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224005344

http://www.w3.org/2001/XMLSchema#string

P698

22498805

http://www.w3.org/2001/XMLSchema#string

P932

3379604

http://www.w3.org/2001/XMLSchema#string